Info

Montigen will discover and develop novel promising compounds for license or co-development with select pharmaceutical and biotechnology partners. The company will also utilize its proprietary technology in partnership with select partners. Our primary therapeutic focus is oncology. Montigen is keenly interested in discussing opportunities for potential strategic alliances with pharmaceutical and biotechnology companies to assist in the development and commercialization of our lead candidates.